Trifluoroacetic acid → 5-(2-ureidoethoxy)-7-chloro-1-[2-methoxy-4-(2-chloro-benzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzoazepine

HRID 54756

Reaktionsgleichung

Reaktionsgleichung von HRID 54756
[O-:1][C:2]#[N:3].[Na+].FC(F)(F)C(O)=O.[NH2:12][CH2:13][CH2:14][O:15][CH:16]1[C:22]2[CH:23]=[C:24]([Cl:27])[CH:25]=[CH:26][C:21]=2[N:20]([C:28](=[O:47])[C:29]2[CH:34]=[CH:33][C:32]([NH:35][C:36](=[O:44])[C:37]3[CH:42]=[CH:41][CH:40]=[CH:39][C:38]=3[Cl:43])=[CH:31][C:30]=2[O:45][CH3:46])[CH2:19][CH2:18][CH2:17]1.C(=O)([O-])O.[Na+]>CN(C)C=O.CCCCCC>[NH:12]([CH2:13][CH2:14][O:15][CH:16]1[C:22]2[CH:23]=[C:24]([Cl:27])[CH:25]=[CH:26][C:21]=2[N:20]([C:28](=[O:47])[C:29]2[CH:34]=[CH:33][C:32]([NH:35][C:36](=[O:44])[C:37]3[CH:42]=[CH:41][CH:40]=[CH:39][C:38]=3[Cl:43])=[CH:31][C:30]=2[O:45][CH3:46])[CH2:19][CH2:18][CH2:17]1)[C:2]([NH2:3])=[O:1]

Komponenten

7

Edukt 4

HCID 6422Trifluoroacetic acidHCID 516892Sodium BicarbonateHCID 517096Sodium CyanateHCID 189172105-(2-aminoethoxy)-7-chloro-1-[2-methoxy-4-(2-chlorobenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzoazepine

Produkt 1

HCID 189171925-(2-ureidoethoxy)-7-chloro-1-[2-methoxy-4-(2-chloro-benzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzoazepineAusbeute 76 %

Reagenzien, Katalysatoren, Lösungsmittel 2

HCID 6228DimethylformamideLösungsmittelHCID 8058HexaneLösungsmittel

Reaktionsbedingungen

Temperatur
80 °C

Versuchsvorschrift

0.12 g of sodium cyanate and 0.22 ml of trifluoro-acetic acid were added to a solution of 0.5 g of 5-(2-amino-ethoxy)-7-chloro-1-[2-methoxy-4-(2-chlorobenzoylamino)-benzoyl]-2,3,4,5-tetrahydro-1H-benzoazepine dissolved in 15 ml of dry dimethylformamide. The mixture was stirred at 80° C. for 1 hour. After cooling, the reaction mixture was mixed with slight amounts of a saturated aqueous sodium hydrogen-carbonate solution and hexane, followed by extraction with ethyl acetate. The organic layer was water-washed, then dried over magnesium sulfate and subjected to vacuum distillation to remove the solvent. The resiude was recrystallized from acetone-n-hexane to obtain 0.41 g (76%) of 5-(2-ureidoethoxy)-7-chloro-1-[2-methoxy-4-(2-chloro-benzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzoazepine.

Aufarbeitung

  1. temperatureAfter cooling
  2. extractionfollowed by extraction with ethyl acetate
  3. washwashed
  4. dry with materialdried over magnesium sulfate
  5. distillationsubjected to vacuum distillation
  6. customto remove the solvent
  7. customThe resiude was recrystallized from acetone-n-hexane

Quellen und Nachweise

ORD-Eintrag
ord-867fbd1a798e4394826c60b2e54d6ee1
Quelldatensatz
uspto-grants-1997_04
Patentnummer
US05622947

Verknüpfte Notizen

Wird geladen…